| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Editorials |
-Glutamyltransferase and Risk of Disease
Department of Clinical Biochemistry, Royal Prince Alfred Hospital, Camperdown, New South Wales, Australia, Fax 61-2-9515-7931, E-mail John.Whitfield@email.cs.nsw.gov.au
| The first 20% of the full text of this article appears below. |
Serum 
-glutamyltransferase (GGT) has long been used as a liver function test and a marker of excessive alcohol use; in recent years our knowledge of GGT’s physiological functions has expanded and several important epidemiological associations have been reported. The paper by Ryu et al. in this issue of Clinical Chemistry (1) extends the range of conditions predicted by GGT to include chronic kidney disease (CKD). Such prospective associations between GGT and disease raise issues in both pure and applied science; first, the pathological significance of the wide range of GGT–disease risk associations, and second, the effects that this information may have on the clinical or preventive use of GGT determinations.
CKD is an increasingly common and important condition (2). Existing laboratory markers include glomerular filtration rate estimated from serum creatinine, sex, age, and race (eGFR), and the presence of proteinuria. Because CKD tends to progress, these markers also have predictive value. Defining the pathological role of GGT in CKD will require more investigation. GGT may be a marker of the pathological process or even a contributor, but in either case, GGT is a novel predictor of CKD that could contribute to early intervention and improved outcomes.
The study by Ryu et al. (1) was carried out on a cohort of Korean men given a regular health check as part of their employment and followed for up to
The following articles in journals at HighWire Press have cited this article:
|
|
 |
|
  N. MUTLU, M. BICAKCIGIL, D. A. TASAN, A. KAYA, S. YAVUZ, and A. I. OZDEN Comparative Performance Analysis of 4 Different Anti-Citrullinated Protein Assays in the Diagnosis of Rheumatoid Arthritis J Rheumatol, March 1, 2009; 36(3): 491 - 500. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Szajli, T. Feher, and K. F. Medzihradszky Investigating the Quantitative Nature of MALDI-TOF MS Mol. Cell. Proteomics, December 1, 2008; 7(12): 2410 - 2418. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D.-H. Lee, M. D. Gross, M. W. Steffes, and D. R. Jacobs Jr Is Serum Gamma-Glutamyltransferase a Biomarker of Xenobiotics, Which Are Conjugated by Glutathione? Arterioscler Thromb Vasc Biol, April 1, 2008; 28(4): e26 - e28. [Full Text] [PDF]
|
|
|
|
 |
|
 S. W. Leonard, J. D. Joss, D. J. Mustacich, D. H. Blatt, Y. S. Lee, and M. G. Traber Effects of vitamin E on cholesterol levels of hypercholesterolemic patients receiving statins Am. J. Health Syst. Pharm., November 1, 2007; 64(21): 2257 - 2266. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. T. Murphy, D. R. Witcher, P. Luan, and V. J. Wroblewski Quantitation of hepcidin from human and mouse serum using liquid chromatography tandem mass spectrometry Blood, August 1, 2007; 110(3): 1048 - 1054. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 I. Vanhorebeek, L. Langouche, and G. Van den Berghe Tight Blood Glucose Control With Insulin in the ICU: Facts and Controversies Chest, July 1, 2007; 132(1): 268 - 278. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
